A bipartisan group of senators is proposing to boost funding for research and prevention through 2035.
Alzheimer’s disease
Gov. Mills launches program to give grants up to $2,000 to family caregivers
The $5.1 million program is for family caregivers of patients with disabilities, such as Alzheimer’s and dementia, who are being cared for at home.
Photos: 2022 Walk to End Alzheimer’s
Hundreds of people took part in Saturday morning’s annual walk in Lewiston.
Medicare evaluating coverage for $56,000 Alzheimer’s drug
Although pricey drugs are now fairly commonplace, the recent approval of Aduhelm prompted an unusually intense backlash.
FDA chief calls for investigation into review of controversial new Alzheimer’s drug
It’s the latest fallout over last month’s approval of Aduhelm, an expensive and unproven therapy that the agency OK’d against the advice of its own outside experts.
FDA reverses itself under pressure, moves to limit use of new Alzheimer’s drug
The Food and Drug Administration says the change is intended to address confusion among physicians and patients about who should get Aduhelm, which has faced an intense public backlash since its approval last month.
Controversial new Alzheimer’s drug gives patients in Maine hope
The treatment developed by Biogen could slow its progression, but health professionals and researchers are divided on whether the FDA was right to approve it.
FDA approves new drug for Alzheimer’s that experts doubt will work
The decision is sure to spark disagreements among doctors, medical researchers and patient groups, and have far-reaching implications for the standards used to evaluate experimental therapies.
Maine CDC reports 71 new coronavirus cases as outbreak hits Cape Elizabeth memory care home
The additional cases and 2 deaths come at a time when the Mills administration is relaxing restrictions on businesses to begin reviving Maine’s economy.
Alzheimer’s disease threatens an aging Maine
With the number of Mainers with Alzheimer’s rising rapidly, research at The Jackson Lab and beyond is crucial to slowing its impact on families and taxpayers.